• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人群中肺癌死亡率从 1973-1975 年到 2004-2005 年的增加:吸烟暴露的不良健康影响。

Increased lung cancer mortality rates in the Chinese population from 1973-1975 to 2004-2005: An adverse health effect from exposure to smoking.

机构信息

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

National Office for Cancer Prevention and Control, National Cancer Center, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Cancer. 2015 Sep 1;121 Suppl 17:3107-12. doi: 10.1002/cncr.29603.

DOI:10.1002/cncr.29603
PMID:26331817
Abstract

BACKGROUND

Lung cancer incidence and mortality rates have increased substantially in China despite improvements in clinical diagnosis and treatment approaches as well as significant advances in the implementation of tobacco-control policies in recent decades.

METHODS

Age-standardized mortality rates and age-specific rates of lung cancer in China were estimated for the periods 1973 to 1975, 1990 to 1992, and 2004 to 2005 using data from 3 National Death Surveys. Among patients with lung cancer who were identified from a hospital-based information system, the percentages of ever-smokers were analyzed according to histologic and demographic variables.

RESULTS

Age-standardized mortality from lung cancer in China dramatically increased from 7.30 per 100,000 during 1973 through 1975 to 27.62 per 100,000 during 2004 through 2005. Increases in lung cancer age-standardized mortality were consistent among men and women in urban and rural populations. Among men ages 75 to 79 years, lung cancer mortality increased remarkably to 453.67 per 100,000 in 2004 and 2005 (from 246.78 per 100,000 during 1990-1992 and from 53.65 per 100,000 during 1973-1975). Among 6674 patients with lung cancer who were identified from 2003 to 2007 from a hospital-based database, 82.97% of men were ever-smokers (73.35% of men with adenocarcinoma and 91.8% of men with squamous cell carcinoma), and 11.18% of women were ever-smokers (6% of women with adenosquamous carcinoma and 39.02% of women with squamous cell carcinoma). Differences in the numbers of ever-smokers were observed between age groups but not according to the year of diagnosis.

CONCLUSIONS

The consistent and rapid increases in lung cancer mortality rates observed in the Chinese population and the high prevalence of exposure to smoking in China prompt a strong call for the implementation of a comprehensive tobacco-control policy and specific public health educational strategies.

摘要

背景

尽管近几十年来临床诊断和治疗方法有所改进,以及在实施烟草控制政策方面取得了重大进展,但中国的肺癌发病率和死亡率仍大幅上升。

方法

利用 3 次全国死亡调查的数据,估算了 1973 年至 1975 年、1990 年至 1992 年和 2004 年至 2005 年期间中国肺癌的年龄标准化死亡率和特定年龄的肺癌发病率。从医院信息系统中确定的肺癌患者中,根据组织学和人口统计学变量分析了曾吸烟者的百分比。

结果

中国肺癌的年龄标准化死亡率从 1973 年至 1975 年的每 10 万人 73.0 人急剧上升到 2004 年至 2005 年的每 10 万人 276.2 人。城乡人口中,男性和女性的肺癌年龄标准化死亡率均呈上升趋势。在 75 岁至 79 岁的男性中,2004 年和 2005 年的肺癌死亡率显著上升至每 10 万人 453.67 人(1990-1992 年每 10 万人 246.78 人,1973-1975 年每 10 万人 53.65 人)。从 2003 年至 2007 年从医院数据库中确定的 6674 名肺癌患者中,82.97%的男性是曾吸烟者(腺癌患者中 73.35%,鳞癌患者中 91.8%),11.18%的女性是曾吸烟者(腺鳞癌患者中 6%,鳞癌患者中 39.02%)。在年龄组之间观察到曾吸烟者的数量存在差异,但与诊断年份无关。

结论

中国人群中肺癌死亡率的持续快速上升以及中国人群中吸烟暴露的高流行率强烈呼吁实施全面的烟草控制政策和具体的公共卫生教育策略。

相似文献

1
Increased lung cancer mortality rates in the Chinese population from 1973-1975 to 2004-2005: An adverse health effect from exposure to smoking.中国人群中肺癌死亡率从 1973-1975 年到 2004-2005 年的增加:吸烟暴露的不良健康影响。
Cancer. 2015 Sep 1;121 Suppl 17:3107-12. doi: 10.1002/cncr.29603.
2
GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.谷胱甘肽S-转移酶M1和细胞色素P450 1A1基因多态性、烟草、空气污染与肺癌:泰国农村地区的一项研究
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):667-74. doi: 10.1158/1055-9965.EPI-05-0667.
3
Age-related effects of smoking on lung cancer mortality: a nationwide case-control comparison in 103 population centers in China.吸烟对肺癌死亡率的年龄相关影响:中国103个人口中心的全国性病例对照比较。
Ann Epidemiol. 2008 Jun;18(6):484-91. doi: 10.1016/j.annepidem.2008.01.004. Epub 2008 Apr 28.
4
Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.吸烟史预示着更高的第二原发性肺癌风险:综合分析。
Cancer. 2015 Feb 15;121(4):598-604. doi: 10.1002/cncr.29095. Epub 2014 Oct 3.
5
Mortality from lung cancer and tobacco smoking in Ohio (U.S.): will increasing smoking prevalence reverse current decreases in mortality?美国俄亥俄州肺癌死亡率与吸烟情况:吸烟率上升会扭转当前死亡率下降的趋势吗?
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1182-7. doi: 10.1158/1055-9965.EPI-04-0699.
6
[Study on the relations between smoking and the risk of age-specific lung cancer deaths in urban and rural areas of China].[中国城乡地区吸烟与特定年龄肺癌死亡风险关系的研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Sep;30(9):907-10.
7
Lung carcinoma in former smokers.既往吸烟者的肺癌
Cancer. 1996 Sep 1;78(5):1004-10. doi: 10.1002/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6.
8
Smoking and air pollution exposure and lung cancer mortality in Zhaoyuan County.肇源县的吸烟和空气污染暴露与肺癌死亡率。
Int J Hyg Environ Health. 2013 Jan;216(1):63-70. doi: 10.1016/j.ijheh.2012.06.003. Epub 2012 Jul 28.
9
The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.非小细胞肺癌中吸烟量的预后影响——腺癌与鳞状细胞癌之间的差异
Lung Cancer. 2014 Aug;85(2):125-30. doi: 10.1016/j.lungcan.2014.06.006. Epub 2014 Jun 16.
10
Fumes from meat cooking and lung cancer risk in Chinese women.中国女性烹饪肉类产生的油烟与肺癌风险
Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1215-21.

引用本文的文献

1
Historical data analysis and future prediction of lung cancer in Zhejiang province, China.中国浙江省肺癌的历史数据分析与未来预测。
Sci Rep. 2025 Jul 1;15(1):21813. doi: 10.1038/s41598-025-07200-5.
2
The innovative checkpoint inhibitors of lung adenocarcinoma, cg09897064 methylation and ZBP1 expression reduction, have implications for macrophage polarization and tumor growth in lung cancer.肺癌中创新的检查点抑制剂 cg09897064 甲基化和 ZBP1 表达降低,对肺癌中巨噬细胞极化和肿瘤生长有影响。
J Transl Med. 2024 Feb 18;22(1):173. doi: 10.1186/s12967-024-04995-1.
3
The incidence and mortality of lung cancer in China: a trend analysis and comparison with G20 based on the Global Burden of Disease Study 2019.
中国肺癌的发病率和死亡率:基于《2019年全球疾病负担研究》的趋势分析及与二十国集团的比较
Front Oncol. 2023 Aug 9;13:1177482. doi: 10.3389/fonc.2023.1177482. eCollection 2023.
4
Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis.长链非编码RNA-ICL通过调控微小RNA-19-3p/NKRF/核因子κB轴参与慢性阻塞性肺疾病患者肺癌发生发展的机制
Cancer Cell Int. 2023 Apr 3;23(1):58. doi: 10.1186/s12935-023-02900-2.
5
Emerging roles and therapeutic potentials of ferroptosis: from the perspective of 11 human body organ systems.铁死亡:从 11 个人体器官系统角度看新兴作用和治疗潜力。
Mol Cell Biochem. 2023 Dec;478(12):2695-2719. doi: 10.1007/s11010-023-04694-3. Epub 2023 Mar 13.
6
Meta-analysis of the efficacy and safety of sintilimab for treating advanced non-small cell lung cancer.信迪利单抗治疗晚期非小细胞肺癌疗效与安全性的Meta分析
Oncol Lett. 2022 Oct 12;24(6):425. doi: 10.3892/ol.2022.13545. eCollection 2022 Dec.
7
Implementation planning for lung cancer screening in China.中国肺癌筛查的实施规划。
Precis Clin Med. 2019 Mar;2(1):13-44. doi: 10.1093/pcmedi/pbz002. Epub 2019 Mar 14.
8
Efficacy of PD-1/PD-L1 Inhibitors versus Chemotherapy in Lung Cancer with Brain Metastases: A Systematic Review and Meta-Analysis.PD-1/PD-L1 抑制剂与化疗治疗肺癌脑转移的疗效比较:系统评价和荟萃分析。
J Immunol Res. 2022 May 20;2022:4518898. doi: 10.1155/2022/4518898. eCollection 2022.
9
Characteristics and Predictors of Abstinence Among Smokers of a Smoking Cessation Clinic in Hunan China.中国湖南一家戒烟诊所吸烟者戒烟的特征和预测因素。
Front Public Health. 2021 Mar 19;9:615817. doi: 10.3389/fpubh.2021.615817. eCollection 2021.
10
Influence of -Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy.基因多态性rs822336对接受铂类辅助化疗的非小细胞肺癌术后患者预后及安全性的影响
Cancer Manag Res. 2020 Aug 4;12:6755-6766. doi: 10.2147/CMAR.S255072. eCollection 2020.